Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
0.2671
+0.0019 (0.72%)
At close: Jul 15, 2025, 4:00 PM
0.2745
+0.0074 (2.77%)
After-hours: Jul 15, 2025, 7:57 PM EDT
Co-Diagnostics Market Cap
Co-Diagnostics has a market cap or net worth of $9.00 million as of July 15, 2025. Its market cap has decreased by -77.32% in one year.
Market Cap
9.00M
Enterprise Value
-10.54M
1-Year Change
-77.32%
Ranking
Category
Stock Price
$0.27
Market Cap Chart
Since July 12, 2017, Co-Diagnostics's market cap has decreased from $65.00M to $9.00M, a decrease of -86.15%. That is a compound annual growth rate of -21.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2025 | 9.00M | -62.34% |
| Dec 31, 2024 | 23.90M | -41.28% |
| Dec 29, 2023 | 40.70M | -47.75% |
| Dec 30, 2022 | 77.90M | -69.81% |
| Dec 31, 2021 | 258.00M | -1.86% |
| Dec 31, 2020 | 262.90M | 1,596.13% |
| Dec 31, 2019 | 15.50M | -19.27% |
| Dec 31, 2018 | 19.20M | -40.74% |
| Dec 29, 2017 | 32.40M | -50.15% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.72B |
| Johnson & Johnson | 376.31B |
| AbbVie | 337.10B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 272.11B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.97B |
| AstraZeneca | 218.74B |